Storys aus England

Filtern
  • 08.03.2021 – 08:01

    Novogene Europe

    Novogene Europe Launches Clinical Sequencing Services for its European Customers

    Cambridge, England (ots/PRNewswire) - Novogene Europe, a leading provider of genomic services and solutions, has announced the launch of a Clinical Service to provide its European customers with next-generation sequencing (NGS) services and solutions for their clinical samples. The Clinical Service has launched after Novogene's Cambridge Sequencing Centre was awarded ...

  • 08.12.2020 – 13:00

    Abcam plc

    Abcam reveals new cell engineering facility in Bay Area

    Cambridge, England (ots/PRNewswire) - - State-of-the-art site will enable rapid delivery of engineered cell lines - Powering ready-to-use edited cell-line portfolio expansion - Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility ...

  • 09.10.2020 – 12:47

    Oxford Nanopore Technologies

    LamPORE test for SARS-CoV-2 detection gains CE-IVD mark

    Oxford, England (ots/PRNewswire) - LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C. Following an application to the UK's MHRA, the LamPORE assay is now CE marked for in vitro diagnostic use for the detection of the SARS-CoV-2 virus, using the GridION ...

  • 07.07.2020 – 10:01

    Cancer Research UK; Abcam

    Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Cancer Research

    London and Cambridge, England (ots/PRNewswire) - - Long-term partnership to facilitate cancer research through development of custom antibodies - Agreement to enable global access to resulting reagents and potential diagnostics Today, Cancer Research UK, the world's largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents ...

  • 08.06.2020 – 09:00

    Seqirus

    First Adjuvanted Quadrivalent Influenza Vaccine by Seqirus Receives EU Approval

    Maidenhead, England (ots/PRNewswire) - The European Commission has today given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe. This new vaccine builds on the well-established technology used in an existing adjuvanted trivalent influenza vaccine (aTIV) available in several European countries. aTIV has ...

  • 24.04.2020 – 13:24

    RB

    RB Statement: Improper Use of Disinfectants

    Slough, England (ots/PRNewswire) - Due to recent speculation and social media activity, RB (the makers of Lysol and Dettol) has been asked whether internal administration of disinfectants may be appropriate for investigation or use as a treatment for coronavirus (SARS-CoV-2). As a global leader in health and hygiene products, we must be clear that under no circumstance should our disinfectant products be administered into ...